Published in Emerg Infect Dis on September 01, 2011
Household transmission of 2009 pandemic influenza A (H1N1): a systematic review and meta-analysis. Epidemiology (2012) 1.43
Attack rates assessment of the 2009 pandemic H1N1 influenza A in children and their contacts: a systematic review and meta-analysis. PLoS One (2012) 1.06
Effectiveness of antiviral prophylaxis coupled with contact tracing in reducing the transmission of the influenza A (H1N1-2009): a systematic review. Theor Biol Med Model (2013) 0.91
Influenza transmission in a community during a seasonal influenza A(H3N2) outbreak (2010-2011) in Mongolia: a community-based prospective cohort study. PLoS One (2012) 0.90
Factors associated with household transmission of pandemic (H1N1) 2009 among self-quarantined patients in Beijing, China. PLoS One (2013) 0.79
Prevention of influenza in healthy children. Expert Rev Anti Infect Ther (2012) 0.77
Household Transmission of Influenza Virus. Trends Microbiol (2015) 0.76
Risk factors for community-based reports of gastrointestinal, respiratory, and dermal symptoms: findings from a cohort study in Australia. J Epidemiol (2013) 0.76
Selecting nonpharmaceutical strategies to minimize influenza spread: the 2009 influenza A (H1N1) pandemic and beyond. Public Health Rep (2012) 0.75
Strategies for mitigating an influenza pandemic. Nature (2006) 25.20
Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol (2008) 10.02
Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med (2009) 6.65
The transmissibility and control of pandemic influenza A (H1N1) virus. Science (2009) 6.53
Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med (2010) 5.90
Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis (2009) 4.33
Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. Euro Surveill (2009) 3.30
Household transmission of 2009 influenza A (H1N1) virus after a school-based outbreak in New York City, April-May 2009. J Infect Dis (2010) 2.85
Australia's winter with the 2009 pandemic influenza A (H1N1) virus. N Engl J Med (2009) 2.60
Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratory‐confirmed secondary attack rates and evidence of asymptomatic infections. Clin Infect Dis (2010) 2.41
Early transmission characteristics of influenza A(H1N1)v in Australia: Victorian state, 16 May - 3 June 2009. Euro Surveill (2009) 2.05
Pandemic H1N1 influenza surveillance in Victoria, Australia, April - September, 2009. Euro Surveill (2009) 1.89
The Early Transmission Dynamics of H1N1pdm Influenza in the United Kingdom. PLoS Curr (2009) 1.87
Epidemiological characteristics of pandemic influenza H1N1 2009 and seasonal influenza infection. Med J Aust (2009) 1.81
Introduction and transmission of 2009 pandemic influenza A (H1N1) Virus--Kenya, June-July 2009. MMWR Morb Mortal Wkly Rep (2009) 1.73
Household transmission of pandemic (H1N1) 2009, San Antonio, Texas, USA, April-May 2009. Emerg Infect Dis (2010) 1.64
Serial intervals and the temporal distribution of secondary infections within households of 2009 pandemic influenza A (H1N1): implications for influenza control recommendations. Clin Infect Dis (2011) 1.40
Transmission of pandemic influenza A (H1N1) 2009 within households: Edmonton, Canada. J Clin Virol (2010) 1.38
Assessment of secondary attack rate and effectiveness of antiviral prophylaxis among household contacts in an influenza A(H1N1)v outbreak in Kobe, Japan, May-June 2009. Euro Surveill (2009) 1.30
Pandemic (H1N1) 2009 influenza community transmission was established in one Australian state when the virus was first identified in North America. PLoS One (2010) 1.30
Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009. BMC Infect Dis (2010) 1.21
Influenza A (H1N1) in Victoria, Australia: a community case series and analysis of household transmission. PLoS One (2010) 1.19
Household transmission of pandemic 2009 influenza A (H1N1) virus in Osaka, Japan in May 2009. J Infect (2010) 1.08
A school outbreak of pandemic (H1N1) 2009 infection: assessment of secondary household transmission and the protective role of oseltamivir. Epidemiol Infect (2010) 1.00
Household transmission of 2009 pandemic influenza A (H1N1) and nonpharmaceutical interventions among households of high school students in San Antonio, Texas. Clin Infect Dis (2011) 0.95
Quarantine methods and prevention of secondary outbreak of pandemic (H1N1) 2009. Emerg Infect Dis (2010) 0.85
The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology (2013) 3.14
Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals. Hepatology (2013) 2.76
Immediate recall of health issues discussed during a pre-travel consultation. J Travel Med (2015) 2.61
Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection. Hepatology (2010) 2.56
Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection. Clin Infect Dis (2008) 2.20
Effective treatment of injecting drug users with recently acquired hepatitis C virus infection. Gastroenterology (2009) 1.99
The MJA and Gawler: a case of self-censorship? Med J Aust (2012) 1.92
Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling. PLoS Med (2010) 1.83
Epidemiological characteristics of pandemic influenza H1N1 2009 and seasonal influenza infection. Med J Aust (2009) 1.81
Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection. Hepatology (2013) 1.77
A lower than expected adult Victorian community attack rate for pandemic (H1N1) 2009. Aust N Z J Public Health (2010) 1.76
Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine. Lancet Infect Dis (2012) 1.66
A biological model for influenza transmission: pandemic planning implications of asymptomatic infection and immunity. PLoS One (2007) 1.64
Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation. J Infect Dis (2010) 1.63
Similar mortality and reduced loss to follow-up in integrated compared with vertical programs providing antiretroviral treatment in sub-saharan Africa. J Acquir Immune Defic Syndr (2012) 1.58
A multistate outbreak of hepatitis A associated with semidried tomatoes in Australia, 2009. Clin Infect Dis (2012) 1.57
High incidence of hepatitis C virus reinfection in a cohort of injecting drug users. Hepatology (2008) 1.55
Missed immunisation opportunities in emergency departments in northern New South Wales, Australia. J Paediatr Child Health (2011) 1.55
Determining the impact of text messaging for sexual health promotion to young people. Sex Transm Dis (2011) 1.54
Reduced valve replacement surgery and complication rate in Staphylococcus aureus endocarditis patients receiving acetyl-salicylic acid. J Infect (2009) 1.51
Splenectomy sequelae: an analysis of infectious outcomes among adults in Victoria. Med J Aust (2012) 1.49
Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome. AIDS (2013) 1.46
Using a surveillance system to identify and treat newly acquired hepatitis C infection. J Gastroenterol Hepatol (2008) 1.44
Medication chart intervention improves inpatient thromboembolism prophylaxis. Chest (2011) 1.43
Hepatitis C and pregnancy: an update. Aust N Z J Obstet Gynaecol (2003) 1.39
Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) study. Int J Epidemiol (2012) 1.39
Blood-borne viral and sexually transmissible infections among psychiatric populations: what are we doing about them? Aust N Z J Psychiatry (2005) 1.39
IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study. PLoS Med (2011) 1.36
Australian general practitioner chlamydia testing rates among young people. Med J Aust (2011) 1.34
Invasive pneumococcal disease in Australia, 2006. Commun Dis Intell Q Rep (2008) 1.30
Pentavalent rotavirus vaccine and prevention of gastroenteritis hospitalizations in Australia. Pediatrics (2010) 1.30
Impact of pandemic (H1N1) 2009 influenza on critical care capacity in Victoria. Med J Aust (2009) 1.29
Early adherence to antiretroviral medication as a predictor of long-term HIV virological suppression: five-year follow up of an observational cohort. PLoS One (2010) 1.28
Influenza: accounting for prior immunity. Science (2009) 1.28
Formal ontology for natural language processing and the integration of biomedical databases. Int J Med Inform (2005) 1.24
Queer as F**k: reaching and engaging gay men in sexual health promotion through social networking sites. J Med Internet Res (2013) 1.23
Chemokine levels and chemokine receptor expression in the blood and the cerebrospinal fluid of HIV-infected patients with cryptococcal meningitis and cryptococcosis-associated immune reconstitution inflammatory syndrome. J Infect Dis (2013) 1.18
A chlamydia prevalence survey of young women living in Melbourne, Victoria. Sex Health (2006) 1.18
Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period. Haematologica (2011) 1.17
Inhibition of telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide reverse transcriptase inhibitors: a potential factor contributing to HIV-associated accelerated aging. J Infect Dis (2013) 1.16
Acetyl salicylic acid usage and mortality in critically ill patients with the systemic inflammatory response syndrome and sepsis. Crit Care Med (2012) 1.15
Prior immunity helps to explain wave-like behaviour of pandemic influenza in 1918-9. BMC Infect Dis (2010) 1.14
Further evidence of HCV sexual transmission among HIV-positive men who have sex with men: response to Danta et al. AIDS (2007) 1.11
Modelling the hepatitis C virus epidemic in Australia. Drug Alcohol Depend (2007) 1.08
Analysis of FOXP3+ regulatory T cells that display apparent viral antigen specificity during chronic hepatitis C virus infection. PLoS Pathog (2009) 1.08
Risk factors for HIV seroconversion in men who have sex with men in Victoria, Australia: results from a sentinel surveillance system. Sex Health (2011) 1.07
Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection. Hepatology (2012) 1.07
Hepatitis C virus phylogenetic clustering is associated with the social-injecting network in a cohort of people who inject drugs. PLoS One (2012) 1.07
Measuring the accuracy of self-reported height and weight in a community-based sample of young people. BMC Med Res Methodol (2012) 1.06
Bronchiectasis is associated with human T-lymphotropic virus 1 infection in an Indigenous Australian population. Clin Infect Dis (2011) 1.04
Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis. Ann Neurol (2015) 1.04
Sexual health promotion on social networking sites: a process evaluation of The FaceSpace Project. J Adolesc Health (2013) 1.03
Incentive payments to general practitioners aimed at increasing opportunistic testing of young women for chlamydia: a pilot cluster randomised controlled trial. BMC Public Health (2010) 1.03
Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach. Antimicrob Agents Chemother (2011) 1.02
SPL7013 Gel (VivaGel®) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans. PLoS One (2011) 1.01
Chlamydia testing in general practice - a survey of Victorian general practitioners. Sex Health (2006) 1.01
TB incidence and characteristics in the remote gulf province of Papua New Guinea: a prospective study. BMC Infect Dis (2014) 1.01
Reliability and validity of the Kessler 10 and Patient Health Questionnaire among injecting drug users. Aust N Z J Psychiatry (2007) 1.01
Dosing regimens of cotrimoxazole (trimethoprim-sulfamethoxazole) for melioidosis. Antimicrob Agents Chemother (2009) 0.99
Postal surveys of physicians gave superior response rates over telephone interviews in a randomized trial. J Clin Epidemiol (2006) 0.98
Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users. J Hepatol (2010) 0.98
Hepatitis C transmission and treatment in contact networks of people who inject drugs. PLoS One (2013) 0.98
Assessment of clinical risk predictive rules for invasive candidiasis in a prospective multicentre cohort of ICU patients. Intensive Care Med (2009) 0.97
Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database. PLoS One (2011) 0.96
Recommendations for and compliance with social restrictions during implementation of school closures in the early phase of the influenza A (H1N1) 2009 outbreak in Melbourne, Australia. BMC Infect Dis (2011) 0.96
Food subsidy programs and the health and nutritional status of disadvantaged families in high income countries: a systematic review. BMC Public Health (2012) 0.96
Public health response to imported case of poliomyelitis, Australia, 2007. Emerg Infect Dis (2009) 0.95
The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study design. J Infect Dis (2012) 0.95
Who gives pertussis to infants? Source of infection for laboratory confirmed cases less than 12 months of age during an epidemic, Sydney, 2009. Commun Dis Intell Q Rep (2010) 0.95
Risk factors for incident HIV infection in men having sex with men: a case-control study. Sex Health (2007) 0.95
The feasibility of recruiting young men in rural areas from community football clubs for STI screening. Aust N Z J Public Health (2007) 0.94
Impact of revising the National Nosocomial Infection Surveillance System definition for catheter-related bloodstream infection in ICU: reproducibility of the National Healthcare Safety Network case definition in an Australian cohort of infection control professionals. Am J Infect Control (2009) 0.93
The epidemiology of hepatitis C in Australia: notifications, treatment uptake and liver transplantations, 1997-2006. J Gastroenterol Hepatol (2009) 0.92
Incidence of WHO stage 3 and 4 conditions following initiation of anti-retroviral therapy in resource limited settings. PLoS One (2012) 0.92
Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunities. Vaccine (2010) 0.91
Avoiding Guillan-Barré Syndrome following swine origin pandemic H1N1 2009 influenza vaccination. J Infect Dis (2009) 0.90
Predictors of raised viral load during antiretroviral therapy in patients with and without prior antiretroviral use: a cross-sectional study. PLoS One (2013) 0.90
The Australian Multiple Sclerosis (MS) immunotherapy study: a prospective, multicentre study of drug utilisation using the MSBase platform. PLoS One (2013) 0.90
Time of Day and Day of Week Trends in EMS Demand. Prehosp Emerg Care (2015) 0.90
Impact of HIV-associated conditions on mortality in people commencing anti-retroviral therapy in resource limited settings. PLoS One (2013) 0.90
Increases in newly acquired HIV infections in Victoria, Australia: epidemiological evidence of successful prevention? Sex Health (2013) 0.89
Positive surgical margins: rate, contributing factors and impact on further treatment: findings from the Prostate Cancer Registry. BJU Int (2014) 0.89
A mathematical model investigating the impact of an environmental reservoir on the prevalence and control of vancomycin-resistant enterococci. J Infect Dis (2006) 0.89
Naturally occurring dominant drug resistance mutations occur infrequently in the setting of recently acquired hepatitis C. Antivir Ther (2014) 0.89
Cryptococcosis-IRIS is associated with lower cryptococcus-specific IFN-γ responses before antiretroviral therapy but not higher T-cell responses during therapy. J Infect Dis (2013) 0.89
Re-testing for chlamydia at sexual health services in Australia, 2004-08. Sex Health (2011) 0.89
Behavioural interventions for preventing hepatitis C infection in people who inject drugs: a global systematic review. Int J Drug Policy (2011) 0.88
Antigen-driven patterns of TCR bias are shared across diverse outcomes of human hepatitis C virus infection. J Immunol (2010) 0.88
A new national Chlamydia Sentinel Surveillance System in Australia: evaluation of the first stage of implementation. Commun Dis Intell Q Rep (2010) 0.88
Prevalence survey of dermatological conditions in mountainous north India. Int J Dermatol (2012) 0.87
Stop the drama Downunder: a social marketing campaign increases HIV/sexually transmitted infection knowledge and testing in Australian gay men. Sex Transm Dis (2012) 0.87
Dynamics of HCV RNA levels during acute hepatitis C virus infection. J Med Virol (2014) 0.87
Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infection. J Gastroenterol Hepatol (2012) 0.86
Sources, perceived usefulness and understanding of information disseminated to families who entered home quarantine during the H1N1 pandemic in Victoria, Australia: a cross-sectional study. BMC Infect Dis (2011) 0.86
Heterosubtypic T-cell responses against avian influenza H5 haemagglutinin are frequently detected in individuals vaccinated against or previously infected with human subtypes of influenza. Influenza Other Respir Viruses (2008) 0.86
Indications of immune protection from hepatitis C infection. J Urban Health (2004) 0.86
Change in hepatitis C virus genotype in injecting drug users. J Med Virol (2004) 0.86
Measles immunity and immunisation status in Australian children 1 to 4 years of age. J Paediatr Child Health (2006) 0.86